2 most recent filings and news items mentioning LTRN. Updated every 60 seconds.
RestructuringAug 3, 2026Neutral
Lantern has established a separate company, Open-Medicine AI, to commercialize its withZeta.ai platform by licensing technology and assets, aiming to leverage the projected growth in AI drug discovery.
View filing at SEC.gov →
OtherJun 1, 2026Neutral
Lantern Pharma Inc. submitted an 8-K filing with SEC containing exhibit materials. The filing lacks specific material information from the provided text excerpt.
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.